Navigation Links
Testimony to Congress Denounces FDA Reliance on Self-Policing
Date:2/26/2008

TARPON SPRINGS, Fla., Feb. 26 /PRNewswire-USNewswire/ -- John Williams, a shrimp fisherman and executive director of the Southern Shrimp Alliance, testified today before the House Subcommittee on Oversight and Investigations of the Commerce and Energy Committee regarding import seafood safety. Williams criticized the Food and Drug Administration's (FDA) reliance on importers to verify food safety and recommended Congress take legislative actions.

"On behalf of the U.S. shrimp industry, I would like to thank Representative Charles Melancon for inviting us to share our experiences with Congress," said Williams. "We appreciate his continued support for equal application of food safety requirements on imported and domestic seafood."

"The FDA has failed to enforce food safety laws on imported seafood. The FDA's approach to imported food safety is to accept unverified representations from importers with only token inspections," explained Williams.

Concerns about the FDA's inability to assure the safety of imported seafood have caused at least eight states to conduct their own testing programs. Repeatedly, these states have found banned substances in the imports they test-seafood allowed by the FDA and the private sector to enter the U.S. market.

Since 2002, the state of Louisiana has had an Emergency Rule in place to test imported shrimp and crawfish for chloramphenicol. It added testing for fluoroquinolones in Chinese and Vietnamese seafood in 2007.

The impact of FDA's failures

The FDA's failure to prevent the importation of contaminated shrimp has a number of negative effects on the U.S. market, the U.S. shrimp industry and U.S. consumers that benefit from a diet of healthful seafood. First and foremost, farmed-shrimp imports contaminated with banned antibiotics, pesticides and other dangerous contaminants put the health of U.S. consumers at serious risk according to sound medical science that is recognized and applied worldwide.

Second, U.S. consumers are quite often unable to distinguish between safe and unsafe shrimp in retail markets and restaurants. Their fear of buying or being served contaminated imported shrimp depresses the overall consumption and demand for all shrimp, including healthful, wild-caught shrimp produced in the United States.

Finally, the FDA's lax inspection system allows volumes of low-value contaminated shrimp into the U.S. market. These illegal shipments depress the price for U.S. shrimp fishermen.

SSA is an alliance of the U.S. wild-caught shrimp fishery from eight states: North Carolina, South Carolina, Georgia, Florida, Alabama, Mississippi, Louisiana and Texas. For more information, please visit http://www.shrimpalliance.com.

Contact:

Deborah Long

Deborah@CohesiveCommunications.com

785.539.5218


'/>"/>
SOURCE Southern Shrimp Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NCPA President Steve Girouxs Testimony at FDA Behind the Counter Hearing
2. Governors Health Plan Hides the True Cost of a Mandatory Purchase Requirement, Testimony Shows
3. SHRM Testimony Urges Congress to Fix FMLA
4. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
5. Governor Rendell Tells Congress Prescription for Pennsylvania Will Improve Health Care Climate for Small Businesses
6. Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress A Design for a Bundled End Stage Renal Disease Prospective Payment System
7. Congressman Buchanan Tours Florida Clinical Laboratory; Learns Vital Role in Patient Care
8. Congressman Altmire Tours Womens Health Clinical Laboratory; Learns Vital Role in Patient Care
9. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
10. Congresswoman Sutton Leads National Effort to Place Life-Saving AEDs in Americas Schools
11. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... 4th, 2016 questioned the use of the HyProCure sinus tarsi implant. ( ... procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, to correct ...
(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has ... go for gold in Rio. Under the care of Maximized Living doctors at ... In an unprecedented showing, Maximized Living is sending the largest contingent of elite chiropractors ...
(Date:4/29/2016)... ... April 30, 2016 , ... Mercy College is expanding its Graduate Business ... will be expanding due to high demand: Master of Business Administration (MBA), Master of ... summer. , School of Business Graduate Program Chair Dr. Ray Manganelli said: ...
(Date:4/29/2016)... ... April 29, 2016 , ... Since launching its annual volunteer ... serving the footwear industry, has broken all previous participation records in its first ... 23 states during the months of April and May, the 2016 Footwear Cares ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Spiritual Awakening , announces the addition Onnit brand Alpha BRAIN and New Mood ... of Onnit brain and mood optimization products to the store is just one ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... April 28, 2016   Acsis , a leading ... leading IT market research and advisory firm IDC has ... IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 ... provides an assessment of the capabilities and business strategies ... software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... MARLBOROUGH, Mass., April 27, 2016  Hologic, Inc. ... Company,s financial results for the fiscal second quarter ... share (EPS) of $0.24 increased 41.2%, and non-GAAP ... $693.3 million increased 5.8% on a reported basis, ... "We posted another good quarter, highlighted ...
Breaking Medicine Technology: